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ABSTRACT 
 
 Peptide deformylase (PDF) is a bacterial metalloenzyme responsible for cleaving the 
formyl group from nascent polypeptides, aiding in their maturation.  Because it is essential for 
the survival of bacterial cells and does not appear to play a necessary role in humans, PDF is an 
attractive antibacterial target.  Actinonin is a naturally occurring compound that acts as a 
substrate analog to bind PDF and inhibit the enzyme’s activity, therefore providing a potential 
template for developing new antibiotics.  Described here are various dynamic features of PDF 
and the PDF-actinonin complex and thermodynamic properties of the binding event of actinonin 
to PDF. 
 Isothermal titration calorimetry (ITC) experiments were performed to provide 
thermodynamic information (KA, ∆G, ∆H, and  ∆S) about the binding of actinonin to PDF.  First, 
because the identity of the bound divalent metal affects the catalytic activities of PDF, the 
thermodynamics of actinonin binding to Ni-, Co-, and Zn-PDF were explored.  The association 
constant (KA) was found to be highest for Zn-PDF and similar for the Ni- and Co-bond protein.  
These data also showed a correlation between the efficiency of catalysis (kcat/KM) and the 
thermodynamics (∆H, ∆S) of actinonin binding.  To assess the degree to which changes in 
protein motions contribute to binding, the change in heat capacity (∆Cp) between the free and 
bound state was determined by measuring the temperature dependence of the enthalpy change, 
∆H, upon binding.  The effects of salt concentration and buffer on the ∆H were assessed to 
control for binding-linked processes that could contribute to the measured change in heat 
capacity.  The value of ∆Cp, -177.5 cal/mol·K, is larger in magnitude than the value expected from 
changes in molecular surface hydration, consistent with the hypothesis that changes in molecular 
motion do contribute to the thermodynamics of actinonin binding.   
To characterize the effect of actinonin binding on the stability and motions in PDF, 
hydrogen-deuterium (H/D) exchange experiments using nuclear magnetic resonance (NMR) 
spectroscopy were performed on both free and actinonin-bound PDF.  The binding of actinonin 
resulted in a large increase in protection of amide bonds in the binding pocket of PDF and 
entropically favored decreases of protection of amide bonds on the opposite side of the protein. 
These results are consistent with previous relaxation data. 
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Chapter 1: Introduction 
 
Importance of novel antibiotics 
 Antibiotic resistance is a growing complication in the treatment of bacterial infections.  
The widespread prescription of antibiotics and their misuse in the last fifty years has led the 
emergence of antibiotic resistant bacteria, limiting the usefulness of many classes of antibiotics.  
In fact, about 70% of bacteria that cause infection in hospitals are resistant at least one type of 
antibiotic (1) and over 1,000 people die each year due to various strains methicillin-resistant 
Staphylococcus aureus (MRSA) (2).  Another particularly threatening bacterium, multi-drug 
resistant Mycobacterium tuberculosis (MDR-TB) is resistant to the most potent antibiotics that 
are available and is currently running rampant in overcrowded Russian prisons (3).  It is only a 
matter of time until this strain infiltrates large cities everywhere on the globe.  Therefore, it is 
urgent that scientists, physicians, and clinicians develop new antibiotics to overcome this 
problem. 
 Today bacteria are developing antibacterial resistances faster than scientists can develop 
new treatments.  To avoid a potential pandemic, scientists need to expedite current methods of 
drug discovery and development.  The traditional method for novel drug discovery is a random 
screening method, which involves screening microbes from countless soil samples in hopes of 
finding naturally occurring antibiotics.  This method, although it has advantages, is very time- 
and labor-intensive and has various limitations (4).  Another method currently used to develop 
new drugs is to slightly alter already available drugs to reinitiate their effectiveness.  This 
method, however, is also limited in that the new compound will often have a smaller bacterial 
spectrum for which it is useful and different classes of antibiotics will not likely be discovered.  
Structure-based drug design is a third method of drug discovery and development that has 
recently been gaining popularity.  In structure-based drug design of antibiotics, one incorporates 
the knowledge of the structure and dynamics of a bacterial protein into the design a new ligand, 
made from scratch, which will interact with the protein and change its activity.  Bacterial 
enzymes are promising molecules to investigate because their active sites constitute a binding 
site to which a specific ligand can bind.  An analog of the natural substrate can make an effective 
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drug.  A large and often difficult requirement for design of a novel drug is a complete 
characterization of the factors that govern binding. 
 The binding of two molecules is regulated by the thermodynamics of the binding event, 
in particular, the overall change in free energy accompanying binding.  The change in free 
energy is defined as:  
∆G = ∆H – T∆S 
where ∆G is the change in Gibbs free energy, ∆H is the change in enthalpy, T is temperature, 
and ∆S is the change in entropy.  Change in heat and energy can contribute to ∆H, as well as the 
change in exposed surface area or a molecule.  ∆S is essentially a measure of “disorder”.  
Conformational entropy, rotational/translational entropy, and the hydrophobic effect can all 
contribute to ∆S.  Structural and dynamical properties of the system can help elucidate these 
parameters.  For example, S2 values can be obtained through ModelFree analysis from which ∆S 
values can be calculated.  It is these thermodynamic parameters that must be defined for a 
comprehensive understanding of the mobility of the drug target, which in turn will facilitate drug 
development. (5, 6) 
 
Peptide Deformylase 
 Protein synthesis in all prokaryotes is initiated by an N-formylmethionine residue.  
Maturation of a vast majority of the proteins includes the removal of the N-formyl moiety, a step 
that is often necessary to generate a functional protein.  This cleavage is performed by peptide 
deformylase (PDF).  Roughly 50% of proteins also require a second step in maturation, the 
removal of the N-terminal methionine residue which is undertaken by methionine amino 
peptidase (MAP).  MAP cannot perform its peptidase activity with the N-formyl group still on 
the methionine (7). 
 Although eukaryotic cells do not initiate their peptide synthesis with an N-formylated 
methionine and do not require PDF for maturation, a gene homologous to the one for PDF in 
bacteria is present in the genome of eukaryotic mitochondria and chloroplasts (8).  This 
homology was not obvious at first because the overall sequence is not highly conserved among 
prokaryotic and eukaryotic nuclear PDF, but the three-dimensional structures are surprisingly 
conserved.  Modest differences in the substrate binding pocket of Arabidopsis thaliana and 
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Figure 1.1  Backbone cartoon diagram of E. 
coli Zn-PDF.  Cys90, His132, and His136 are 
shown as sticks.  The active site metal ion 
(Zn2+) is shown as a purple sphere,  PDB ID: 
1BS5 
bacterial PDF suggest that specificity could be incorporated into a new antibacterial drug.  The 
tertiary structure of a human nuclear PDF will aid in this understanding (9). 
 E. coli peptide deformylase (PDF) has proven 
to be an excellent model to study dynamics and ligand 
binding for novel drugs.  PDF is highly conserved in 
the kingdom of Bacteria and is essential for them to 
thrive.  E. coli peptide deformylase is a 19.2 kDa 
protein consisting of 168 amino acids.  Residues 1-147 
compose the catalytic core while the last 21 residues 
form a C-terminal α-helix that is not essential for 
activity and is not present in other organisms such as 
Streptococcus pyogenes, Streptococcus pneumonia, 
and Clostridium beijerinckii (10).  The E. coli PDF 
structure includes a divalent cation coordinated in a 
tetrahedral arrangement with two histidine residues, His132 and His136, a cysteine residue, Cys90, 
and a water molecule.  The two histidine residues are present in a conserved HEΦDH motif and 
the cysteine residue is the middle of a conserved EGCΦS motif, where Φ is any hydrophobic 
amino acid (7) (figure 1.1).  Another highly conserved GΦGΦAAxQ motif lies adjacent to the 
binding pocket, where x is any amino acid.  The divalent cation to which PDF is complexed is a 
ferrous ion in vivo (11).  This form of PDF, however, is difficult to work with in the laboratory 
because the ferrous ion oxidizes to a ferric ion upon exposure to air.  Zinc, nickel, and cobalt are 
practical substitutes and do not significantly change the structure of PDF (12, 13, 14, 15).  The 
structures of PDF from several organisms in the presence of various metals and inhibitors have 
been solved by x-ray crystallography and NMR spectroscopy (11, 16-27).  These structures show 
that PDF consists of three α-helices, three 310 helices, and seven β-strands which create three 
anti-parallel β-sheets.  The residues present in PDF’s active site are highly conserved. 
 The structure of PDF is homologous to a family of zinc metalloproteases that are present 
in humans and responsible for tissue repair.  Human enzymes in this family include thermolysin, 
stromelysin, and angiotenisin-converting enzyme (14, 28).  Activities of these enzymes are vital 
in avoiding pathological conditions such as arthritis, multiple sclerosis, and hypertension (29, 
30).  The similarities between PDF and this zinc metalloprotease family create the challenge of 
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Figure 1.2  a. Actinonin (15), b. 
BB-3497 (32), c. BB-83698 (32), 
d.  LBM415 (34) 
developing a drug specific enough to eliminate PDF activity and allow the activities of the 
human enzymes to remain uninhibited.  Comprehensive investigation of ligand binding in PDF is 
essential to circumvent this caveat. 
 It is not a question of “if” bacterial resistance to PDF-targeting drugs will emerge, but 
“when”.  It is possible for bacteria to become resistant to a PDF inhibitor by eliminating the 
initial formylation of the N-terminal methionine residue, an action performed by methionyl-
tRNAfMet formyltransformylase.  It has been shown that these mutants are not as healthy as wild-
type bacteria, but can still flourish (9).   
 
Actinonin as a drug template 
 Actinonin is a naturally occurring PDF inhibitor that 
was isolated in 1960 from Streptomyces and identified as a 
potential antibiotic (mechanism unknown) via random 
screening techniques (figure 1.2 a.) (31).  Peptide deformylase 
was not even identified until 8 years later and in 2000 it was 
recognized that actinonin inhibits PDF (15, 31).  Actinonin 
inhibits PDF in vitro, displays tight binding with a Ki value 
(where 50% of the protein is inhibited) of 0.3 nM and 
demonstrates bacteriostatic activity against a wide range of 
Gram-positive and Gram-negative bacteria.  The inhibition 
mechanism involves binding of a hydroxamate group on the 
inhibitor to the metal ion of PDF.  Actinonin itself is toxic to 
human cells because it inhibits other amino peptidases such as 
seminal alanyl aminopeptidase (15). Importantly, only the 
hydroxamate group on the chemical structure of the inhibitor 
is essential for antibacterial activity; the rest of the molecule 
can be altered.  
 BB-3497 is a molecule derived from actinonin that has 
a Ki of 7 nM and, unlike actinonin, it is orally bioavailable 
(Figure 1.2 b.) (32).  Excitingly, it was shown in mice that 
BB-3497 is effective against a methicillin resistant strain of S. 
a. 
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Figure 1.3.  a. An ITC isotherm, b. an ITC 
thermogram. 
aureus!  BB-83698 is another actinonin derivative which became the first PDF inhibitor to 
advance to phase one clinical trials in 2004 (Figure 1.2 c.) (7, 33).  One year later another PDF 
inhibitor, LBM415, progressed to clinical trials (Figure 1.2 d.) (34). 
 
Isothermal Titration Calorimetry 
To explore the nature of the PDF-
actinonin binding event isothermal titration 
calorimetry (ITC) experiments were performed.  
ITC can directly measure the change of enthalpy, 
∆H, associated with the binding reaction and the 
binding constant, KA, can be calculated by fitting 
the binding curve.  In ITC, one binding partner is 
placed in a cell and the calorimeter measures 
exactly how much power needs to be put into the 
cell to maintain a fixed temperature.  Small 
injections of the other binding partner are 
infused into the cell and, as the binding event 
takes place, heat will be either released or 
absorbed by the reaction depending on whether 
the event is exothermic or endothermic.  A thermogram of power (µcal/sec) vs. time (min) is 
generated where the spikes represent the power surge following each injection (Figure 1.3 a.).  
An isotherm is constructed by plotting the area under each spike vs. the molar ratio of titrant to 
analyte, which is calculated by the starting concentrations of each species (Figure 1.3 b.).  The 
isotherm (plot of areas) can be fit to an equation with which one can deduce ∆H, which is 
essentially the difference between the maximum binding energy released/absorbed and the 
baseline.  The thermodynamic quantities that were measured with ITC, KA and ∆H, can be used 
to calculate the change in free energy, ∆G, and the change in entropy, ∆S, using fundamental 
thermodynamic relationships: 
∆G = -RTln(KA) 
and      ∆G = ∆H - T∆S. 
a 
b 
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 Despite similarities between the crystal structures of PDF containing zinc, cobalt, nickel, 
and iron, it has been shown that the zinc chelated peptide deformylase (Zn-PDF) has a much 
lower efficiency of catalysis than the iron (Fe-PDF, the natural form of PDF), cobalt (Co-PDF), 
or nickel (Ni-PDF) forms (14, 35).  It has also been shown that the binding of actinonin to Zn-
PDF is tighter than that of Fe-PDF, Ni-PDF, or Co-PDF, suggesting that Zn-PDF may bind the 
substrate too tightly for the enzyme to accomplish its function.  The data gathered from ITC will 
help explain these phenomena. 
 Two ITC experiments were performed earlier by a former graduate student in the Foster 
Laboratory: an actinonin/Zn-PDF binding titration at 27°C and one at 37°C.  Only one run per 
set of conditions was performed and only five or six data points defined the transition regions of 
the curves, which is used to calculate KA.  These experiments were repeated to better define the 
KA. 
 
Hydrogen/Deuterium Exchange Using Nuclear Magnetic Spectroscopy 
By comparing the crystal structures of free and actinonin-bound PDF it has been 
suggested that there is a loss of internal motion within PDF when it binds to actinonin (5) and, 
therefore, a loss of conformational entropy.  However, this appears to be offset by a gain in 
entropy from the hydrophobic effect, or the release of water molecules upon burial of non-polar 
surface area.  Since the binding event is driven by a large favorable change in entropy as 
determined by previous, preliminary ITC experiments, the change in the dynamics of side-chain 
residues were thought to play an important role in ligand binding.  Hydrogen/deuterium 
exchange experiments that provide residue-specific thermodynamic information were undertaken 
to corroborate this idea.  
To compare the thermodynamics of specific residues in free PDF and actinonin-bound 
PDF, hydrogen/deuterium exchange experiments were preformed using NMR.  NMR is a 
powerful technique that can be used to probe physical, chemical, and structural information 
about a molecule.  There are many ways of utilizing NMR; in this project, two-dimensional 1H-
15N Heteronuclear Single Quantum Coherence (HSQC) spectra were used.  An HSQC spectrum 
shows a signal for every 1H-15N bond in the molecule so, for a protein uniformly labeled with 
15N, there should be one peak for every residue except for proline, which contains a secondary 
13 
nitrogen (and no 1H), plus peaks from amino acid side chains with N-H bonds, such as 
asparagine.   
 When a protein is in solution, the amide protons that are exposed to solvent will exchange 
freely with the protons in the solvent.  The rate of exchange of protons provides direct 
information about the accessibility of the proton to solvent and, consequently, the fold of the 
protein.  A protein made with 1H can be submerged in a deuterated aqueous solution- D2O 
(2H2O).  The amide protons will exchange with the deuterons is solution and, since a bond 
between an 15N and a D will not produce a signal in the 1H-15N HSQC, the rate of exchange can 
be obtained from the rate at which the signal disappears. 
 In folded proteins, nitrogen-bound protons constantly equilibrate between “open” and 
“closed” states that correspond to unfolded and folded states.  Only when an amide group is in 
the open state can the proton be exchanged with a deuteron from the solution. 
exchangedopenNHclosedNH chop kK →→← )()(  
Amide protons can be protected from exchange if they are involved in secondary structures, such 
as an alpha-helix, or buried deep inside the protein.  For exchange rates to be observed for 
protected amides, small-scale local unfolding events must take place often involving breakage of 
hydrogen bonds for access to the solvent (36).  Under normal conditions, the proton exchange 
rate, kex, is given by equilibrium constant, Kop, multiplied by the exchange rate in the open state, 
kch: 
kex = Kopkch. 
The Gibbs free energy of a closed amide is associated with a value Gc, as is the free energy of the 
open state, Go.  The difference between the two states is the change in free energy, ∆G.  The free 
energy associated with each amide can be correlated with the exchange data and represented 
mathematically as: 
∆G = -RTln(Kop) = -RTln(kex/kch), 
where R is the ideal gas constant, 1.987 cal/mol·K, T is the temperature, and Kop, kex, and kch are as 
previously defined.   
By measuring the rate of hydrogen atom exchange for all amides in both free PDF and 
actinonin-bound PDF, how binding of actinonin alters the thermodynamics of each residue in the 
protein can be quantified.  These data can be combined with other dynamic data gathered from 
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relaxation experiments and data calculated from changes in the free and actinonin-bound PDF 
crystal structures to convey exactly what is occurring in the actinonin-PDF binding event. 
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Chapter 2: Expression and Purification of E. coli Peptide Deformylase 
 
The expression and purification protocol for PDF was adapted from the protocol in D.W. 
Byerly’s Ph.D. thesis (5).  E. coli BL21(DE3) cells were transformed with pET-22b-def 
(encoding PDF residues 1-147) using either heat shock or electroporation.  Unlabeled Zn-PDF 
cells were grown in Luria-Bertani broth; 15N-labeled cells, Co-PDF, and Ni-PDF were grown in 
M9 minimal media with 10 mL Eagle basal vitamin mix (Life Technologies) per liter, both 
media supplemented with 50 µg/L carbenicillin.  Cells were incubated in a shaker at 37°C and 
once the culture reached an OD600 of 0.6-0.8, cells were induced by adding 1 mM IPTG.  At this 
time 100 µM ZnCl2, CoCl2, or NiSO4 was added to the medium, depending on the desired cation 
to be chelated to PDF.  The culture was incubated overnight (~18 h).  In the morning, the cells 
were harvested by centrifugation for 30 min at 30,000 g in a Sorvall SS-34 rotor.  The cell pellet 
was resuspended in 30 mL buffer A (20 mM TRIS, pH 8.0, 10 mL NaCl) with 100 µg/mL PMSF 
(Boeringer Manheim) and sonicated for 2 x 5 min with 2 sec pulses.  The solution was 
centrifuged at 30,000 g for 30 min.  The soluble lysate was filtered and loaded onto a 35-mL Q 
Sepharose fast flow column (Pharmacia) previously equilibrated with buffer A.  Protein was 
eluted from the column with a 200 mL linear salt gradient from 10 mM to 1 M NaCl (figures 2.1, 
2.2).  The fractions that included PDF, as indicated on a SDS-PAGE gel, were purified using gel 
filtration column in buffer C (20 mM TRIS, pH 6.8, 10 mM NaCl) at 3 mL/min.  Fractions 
containing PDF were combined and concentrated by ultrafiltration (Centriprep-10, Americon).  
SDS-PAGE gel showed that the protein was purified to near homogeneity (figure 2.3). 
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Fig. 2.1  Chromatogram of protein elution from Q Sepharose column.  PDF eluted between fractions 23 and 30. 
 
 
 
 
Figure 2.2 SDS-PAGE gel of PDF purification from induction to Sepharose Q column. 
 
 
 
 
Figure 2.3  SDS-PAGE gel showing homogeneity of PDF after final step of purification. 
 
PDF 
PDF 
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Table 3.1  The effect of temperature on thermodynamic properties of PDF-actinonin binding. 
Chapter 3: Isothermal Titration Calorimetry 
 
Introduction 
 Isothermal titration calorimetry (ITC) was utilized to explore the thermodynamics of PDF 
binding to actinonin.  ITC offers direct measurements the change in enthalpy, ∆H, and data from 
which the binding constant, KA, can be calculated.  From these quantities, ∆G and ∆S can be 
calculated.  Because of the temperature dependence of ∆H, experiments at different temperatures 
permit the calculation of heat capacity, ∆Cp (37).  All thermograms are shown in the appendix. 
 
Calculation of Heat Capacity 
 The ∆Cp of actinonin binding to PDF was found by performing actinonin-PDF binding 
experiments at different temperatures.  Experiments were performed between 13°C and 43°C at 
6°C intervals.  To determine ∆Cp, data were taken from the experiments performed at 13°C, 
19°C, 37°C, and 43°C; the experiments performed at 25°C and 31°C did not provide crisp 
transitions between unsaturated and saturated enzymes because it is in this range where ∆H is 
near zero and binding is driven by ∆S.  The data were plotted and fit to a linear equation: 
∆H = ∆Cp (T - Th) 
where T = temperature at which the experiment was performed and Th = the temperature at 
which the binding enthalpy is zero (38).  The plot is shown below: 
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Table 3.2 The effect of salt on PDF-actinonin binding. 
∆G was calculated with the equation ∆G = -RTln(KA) and T∆S was calculated by subtracting the 
calculated ∆G from the measured ∆H.  The change in heat capacity (∆Cp) is defined by δ∆H/T; 
therefore, the slope of a line drawn through the data points on a plot of ∆H vs. temperature 
defines ∆Cp.  ∆Cp was calculated to be -177.5 cal/mol·K.  The value of the measured ∆Cp is larger 
than the value expected solely from changes in molecular surface area (-80.8 cal/mol·K) (5). Factors 
that could contribute to this difference are: salt bridge formation, proton uptake, burial of 
interfacial water and/or changes in molecular motions (dynamics) (39, 40).  The burial of 
interfacial water molecules would be observable when comparing the crystal structures of PDF 
free and complexed with actinonin.  No water molecules appear to be buried in the PDF-
actinonin complex crystal structure.  To explore the possibilities of salt bridge formation and 
proton uptake, further ITC experiments were performed. 
 
Testing for Ion Linkage 
 One can determine if ion linkage is taking place by performing ITC experiments in 
solvents with various salt concentrations.  Actinonin was titrated into Zn-PDF in TRIS buffer 
with 10 mM NaCl, 150 mM NaCl, and 300 mM NaCl.  If the rearrangement of atoms in PDF 
caused the formation or disruption of a salt bridge, the binding affinity (KA) of the reaction 
would increase as the salt concentration increases due to stronger electrostatic interactions and 
plot of log(KA) vs. log[NaCl] would exhibit a linear relationship (39).  The results of these 
experiments are shown below. 
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Buffer 
Heat of Ionization 
(kcal/mol) (ref 42) KA (cal/mol) 
Delta H 
(cal/mol) 
TRIS -11.340822 8.25E6 ± 3.4E6 -1416 ± 23.6 
HEPES -4.875717 4.23E6 ± 4.8E5 -1444 ± 14.7 
Cacodylic Acid -0.7170172 9.98E6 ± 8.3E6 -1204 ± 46.7 
 
Table 3.3  ITC in different buffers, testing for proton linkage. 
No correlation between salt concentration and binding affinity is apparent, implying that a salt 
bridge does not form upon the binding of actinonin to PDF. 
 
Testing for Proton Linkage 
 If proton linkage occurs upon ligand binding, it can be observed by performing 
calorimetry experiments at different pHs.  However, because pH may change the shape of the 
protein, experiments were performed in different buffers with different heats of ionization.  If a 
proton uptake from the buffer occurs upon actinonin binding, the change in enthalpy for the 
binding event in different buffers would be drastically different- at least upon an order of 
magnitude (40).  ITC experiments were performed with tris(hydroxymethyl)aminomethane 
(TRIS), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and cacodylic acid 
buffers.  Results are shown below.   
Since the change in enthalpy is insignificant across this range of heat of ionization values, a 
proton uptake does not appear to occur when PDF and actinonin bind. 
 
Comparing Thermodynamic Properties of PDF Complexed with Different Divalent Cations 
 The crystal structures of PDF containing iron (the natural metal), cobalt, nickel, and zinc 
are all similar, but they each have different catalytic activities.  Although Zn-PDF is the least 
active, it binds actinonin the strongest.  ITC experiments were performed with Zn-PDF, Co-PDF, 
and Ni-PDF to determine if thermodynamic properties of the actinonin-binding reactions could 
help explain this phenomenon.  ITC experiments for Fe-PDF were not attempted because of the 
readiness of Fe2+ to oxidize upon exposure to air.  The results are summarized in Table 3.4. 
The metals are listed in the order of highest catalytically activity first and the least active 
last.  With the highest KA value, Zn-PDF binds the ligand the strongest.  These data suggest that 
perhaps Zn-PDF binds the substrate too tightly for efficient catalysis to take place.  In addition, 
20 
Metal 
Cation Size 
(g/mol) 
kcat/KM  
(ref 14 & 34) KA (M) ∆H (cal/mol) ∆G (cal/mol) -T∆S (cal/mol) 
Iron 55.85 3.50E+06         
Cobalt 58.93 1.11E+06 8.35E6 ± 1.94E6 -5079 ± 67.9 -9817 ± 0.22 -4738 ± 67.9 
Nickel 58.69 5.38E+05 6.04E6 ± 2.78E6 -1891 ± 52.3 -9618 ± 0.45 -7727 ± 52.3 
Zinc 65.39 3.10E+04 8.25E6 ± 3.42E6 -1416 ± 23.6 -9809 ± 0.28 -8394 ± 23.6 
 
Table 3.4 Thermodynamic properties of PDF with different divalent cations, T = 37°C. 
the binding of actinonin to Zn-PDF and Ni-PDF is driven primarily by favorable entropic 
changes while the binding of the ligand to Co-PDF is driven by enthalpic and entropic changes.  
It does not appear that the cation size, at least within this range, correlates strongly with catalytic 
efficiency or thermodynamic properties. 
 
Methods 
 PDF was expressed and purified as discussed in Chapter 2.  The protein was concentrated 
to between 32 and 40 µM, as measured by absorbance.  The protein was dialyzed overnight and 
the dialysate was used to dilute the actinonin sample from 25 mM to exactly 10x that of the 
protein.  Both samples were degassed thoroughly.   
ITC measurements were performed using a MicroCal VP-ITC instrument.  The protein 
solution in the cell was stirred at 300 rpm by the syringe to ensure rapid mixing.  59- 5 µM 
injections of actinonin were made into the cell containing PDF with 240 sec between each 
injection.    Data were analyzed using Origin V.7 SR4 MicroCal.  The baseline and the beginning 
and end of each peak were adjusted manually.  The last few points of the titration, after the 
solution was saturated, were averaged and subtracted from each data point to correct for heat of 
dilution.  Origin uses a non-linear, method of least squares via minimization of χ2 and the 
concentrations of the titrant and the analyte to fit the energy flow per injection to an equilibrium 
binding equation, supplying best fit values of the stoichiometry (n), change in enthalpy (∆H), and 
the binding constant (KA) (43). 
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Chapter 4: Hydrogen/Deuterium Exchange 
 
Hydrogen/deuterium exchange experiments were performed to compare residue-specific 
thermodynamic effects of actinonin binding to PDF.  Amide protons in the protein that are 
exposed to solvent will exchange freely with protons in the solvent.  Hydrogen bonding, other 
electrostatic interactions, and tertiary structure in macromolecules impede this exchange process, 
thus slowing the rate of exchange.  However, local unfolding events enable protected protons to 
exchange with the solvent (44).   
  
Results and Discussion 
PDF was diluted to a 90% D2O solution and immediately subjected to NMR.  HSQCs 
were taken at least every hour for 24 hours.  The intensities of each peak was measured and 
plotted as a function of time.  The data were then fit to an exponential curve: 
y = A0*exp(-A1*x)+A2 
where A0 = the y-intercept, A1 = the rate, and A2 = the offset.  The N-H pairs that exchanged 
their protons within the first 15 minutes exchanged too fast for measurement of an accurate rate, 
since it took about 15 min to acquire the first HSQC.  There were also some that did not 
exchange even after 24 h.  Peak assignments were completed by Doug Byerly and Craig 
McElroy from the Foster Laboratory.  An overlay of seven HSQCs over various time points is 
shown in figure 4.1.  Representative plots of residues displaying nice fits are shown in figure 4.2.   
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Figure 4.1  An overlay of seven HSQCs for the free PDF hydrogen-deuterium exchange experiment: T=0 min, 
T=17, T=72, T=128, T=240, T=351, T=597 min. 
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Figure 4.2  A, B, and C display regressions with good fits.  D displays an amide that exchanged too fast for a rate 
to be measured.  E did not exchange within 24 hours. 
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 Exchange experiments show that there are large areas of both free PDF and actinonin-
bound PDF that are completely protected from solvent and do not exchange even after 24 hours 
as well as regions that are exposed to solvent and exchange protons faster than on the minute-
hour time scale.  Rates for 35 residues were measured for free PDF and rates for 44 residues 
were measured for actinonin-bound PDF.  Figure 4.3 shows the measured rates mapped to the 
structure of PDF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Blue = fast
White = slow
Green = prolines
 
 
 
 
 
Figure 4.3 The top cartoon shows PDF free; actinonin-bound PDF is on the bottom.  There is a gradient 
color scheme from white to blue, white indicating slow rate of exchange, blue illustrating fast rate of 
exchange.  Prolines are shown in green, they do not have amide bonds.  Actinonin is orange and the zinc 
atom is yellow.  Arrows indicate regions that are more dynamic in the actinonin bound molecule than in 
the free PDF molecule. 
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Figure 4.4 Differences in proton exchange rates between free and actinonin-bound PDF. 
Notice that neither the amide bonds within alpha helices nor the residues involved in beta-sheets 
exchange within 24 h.  Also, the residues around the binding pocket of PDF become “lighter” 
(more white) upon the binding of PDF.  These changes were expected.  Many residues on the 
distal side of the protein, however, became more dynamic with the binding of actinonin.  The 
regions are particularly apparent are labeled with arrows in Figure 4.3.  The increase in 
flexibility on the region of the protein opposite of the active site offers entropic compensation for 
the decrease of mobility near the binding site.  This is consistent with relaxation data collected 
previously (5). 
 The differences in the rates for each residue were assessed.  Since the kex values are those 
of an exponential decay, to compare the rates directly the following equation was used: 
Difference in rate = 


−−−
boundexfreeex kk )log(
1
)log(
1  
The results are shown below: 
Protection factors are defined as the rate of proton exchange when the amide is in the 
fully solvent-exposed state to the rate of exchange when it is not fully solvent-exposed (36, 45): 
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Figure 4.5 Differences in amide protection factors between free- and actinonin-bound PDF.
exk
k
P int=  
where kint = the intrinsic exchange rate of the amide proton for that residue (these have been 
tabulated for each individual amino acid as a function of temperature and pH) and kex = the 
observed rate of exchange (36).  Therefore, the protection factor is always greater than or equal 
to 1.  By measuring the difference in protection factors between free and bounds states, one can 
determine the degree to which the exposure of solvent has changed and, therefore, any changes 
in structure and/or flexibility within a certain region of the protein. Because the rates trace 
exponential curves, the logarithm is taken to directly compare the values. 
Residues 16-25 and 111-117 compose random coils on side of the protein opposite from the 
binding site.  As the positive differences in protection factor implies, these are residues that, in 
general, are losing protection from solvent when the ligand binds.  Their increase in dynamics 
most likely contributes to this loss of protection.  Whereas residues 87-99 compose a random coil 
in the free PDF structure, hydrogen bonding between actinonin and Gly89 and other electrostatic 
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interactions allow the formation of a beta-sheet in this region (15).  The hydrogen bond that 
forms between Ala98 and Glu88 upon actinonin binding explains the large gain of protection for 
the amide in residue 98.  Electrostatic interactions occur between actinonin and residues in the 
region of Ile44 and cause the gain of protection in that region. 
 
Methods 
 15N-labeled Zn-PDF was expressed and purified as described in chapter 2.  10% D2O and 
1% DSS in D2O were added and the protein was concentrated to approximately 2 mM.  For 
actinonin-bound samples, actinonin was added so that there was 0.1 mM excess to ensure that all 
PDF was bound.  An HSQC was also taken to ensure complete binding of actinonin to PDF.  
Immediately before collecting data, the protein was diluted to a buffer containing 90% D2O.  The 
first HSQC spectrum was collected as soon as possible after the dilution, which was 
approximately 15 minutes because the sample needed to be aligned and the spectrometer tuned, 
matched, shimmed, and prepared to take data.  Spectra were taken at least every hour for 24 
hours.  Data was collected on the Bruker DRX 800 MHz spectrometer at 310 K.  All spectra 
were processed using NMRPipe and analyzed with NMRview.  Intensities of peaks were fit to an 
exponential decay with CurveFit and analyzed using xmgrace.   
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Conclusions and Future Directions 
 Isothermal titration calorimetry (ITC) experiments were performed to provide 
thermodynamic information (KA, ∆G, ∆H, and ∆S) about the binding of actinonin to PDF.  To 
assess the degree to which changes in protein motions contribute to binding, the change in heat 
capacity (∆Cp) between the free and bound state was determined by measuring the temperature 
dependence of the enthalpy change, ∆H, upon binding.  The value of ∆Cp, -177.5 cal/mol·K, is 
larger in magnitude than the value expected from changes in molecular surface hydration.  The 
effects of salt concentration and buffer on the ∆H were assessed and it was found that these 
binding-linked processes do not contribute to the measured change in heat capacity.  Therefore, it 
is changes in molecular motion do contribute to the thermodynamics of actinonin binding.   
To assess the degree to which the divalent cation affects binding, actinonin was bound to 
Ni-, Co-, and Zn-PDF.  The association constant (KA) was found to be highest for Zn-PDF and 
similar for the Ni- and Co-bond protein.  Because the efficiency of catalysis (kcat/KM) is lowest 
for Zn-PDF, it is thought that Zn-PDF binds the substrate too tightly for optimum rate of 
catalysis.  The binding of actinonin to Zn-PDF and Ni-PDF is driven primarily by favorable 
entropic changes while the binding of the ligand to Co-PDF is driven enthalpic forces. 
According to hydrogen-deuterium (H/D) exchange experiments, the binding of actinonin 
results in a large increase in protection of amide bonds in the binding pocket of PDF and 
entropically favored decreases of protection of amide bonds on the opposite side of the protein. 
These results are consistent with previous relaxation data. 
The next phase of my peptide deformylase analysis will include molecular dynamic (MD) 
simulations.  MD simulations are theoretical computer simulations that allow one to place a 
molecule in a virtual environment and allow it to interact under the known laws of physics.  
Using statistical mechanics, the molecule adopts allowed conformations in a certain amount of 
time and, therefore, allows for the study of the dynamics of a molecule. 
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APPENDIX A 
 
ITC Thermograms 
Different temperatures 
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Different salt concentrations 
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Different buffers 
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Different divalent cations 
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Summary of all ITC data  
 
 Date KA Delta H Delta G -T*Delta S 
  (cal/mol) (cal/molK) (cal/molK) (cal/molK) 
Metals      
      
Zinc      
37C 6/10/2005 2.89E+06 -1274 -9164 -7890
37C  1.36E+07 -1557 -10118 -8561
Average  8.25E+06 -1416 -9809 -8394
      
Cobalt      
Co 4/21/2006 4.39E+06 -4242 -9421 -5179
Co 4/22/2006 1.23E+07 -5916 -10056 -4140
Average  8.35E+06 -5079 -9817 -4738
      
Nickel      
      
Ni 7/15/2005 7.44E+06 -1876 -9746 -7870
Ni 7/15/2005 4.59E+06 -1937 -9449 -7512
Ni 7/15/2005 6.10E+06 -1859 -9624 -7765
Average  6.04E+06 -1891 -9618 -7727
      
      
      
Temperatures     
      
13C 6/14/2005 5.14E+06 2133 -9518 -11651
13C 9/7/2005 4.97E+06 3120 -9498 -12618
Average  5.06E+06 2627 -9508 -12135
      
19C 6/14/2005 5.46E+06 1423 -9556 -10979
      
37C 6/10/2005 2.89E+06 -1274 -9164 -7890
37C  1.36E+07 -1557 -10118 -8561
Average  8.25E+06 -1416 -9809 -8394
      
43C 6/15/2006 5.65E+06 -2770 -9577 -6807
43C 9/7/2005 3.53E+06 -3053 -9287 -6234
Average  4.59E+06 -2912 -9432 -6520
      
      
Buffers      
      
TRIS      
37C 6/10/2005 2.89E+06 -1274 -9164 -7890
37C  1.36E+07 -1557 -10118 -8561
Average  8.25E+06 -1416 -9809 -8394
      
37 
 Date KA Delta H Delta G -T*Delta S 
      
HEPES      
HEPES 6/15/2005 4.23E+06 -1444 -9398 -7954
      
Cacodylic acid     
Caco 4/22/2006 1.16E+07 -1050 -10020 -8970
Caco 4/22/2006 8.35E+06 -1357 -9817 -8460
Average  9.98E+06 -1204 -9927 -8723
      
      
      
Salt Concentrations     
      
10 mM      
37C 6/10/2005 2.89E+06 -1274 -9164 -7890
37C  1.36E+07 -1557 -10118 -8561
Average  8.25E+06 -1416 -9809 -8394
      
150 mM 10/14/2005 1.93E+07 -2340 -10333 -7993
150 mM 6/19/2005 3.60E+06 -1652 -9299 -7647
Average  1.15E+07 -1996 -10012 -8016
      
300 mM  15/15/2005 5.46E+06 -2471 -9556 -7085
300 mM  10/2006 3.60E+06 -1839 -9299 -7460
300 mM  10/15/2005 6.91E+06 -1705 -9701 -7996
Average  5.32E+06 -2005 -9540 -7535
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